School of Medical Science and Technology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal 721302, India.
Biomed Mater. 2021 Mar 8;16(4). doi: 10.1088/1748-605X/abe8f2.
The use of medicinal plants is as ancient as human civilization. The development of phytochemistry and pharmacology facilitates the identification of natural bioactive compounds and their mechanisms of action, including against cancer. The efficacy and the safety of a bioactive compound depend on its optimal delivery to the target site. Most natural bioactive compounds (phenols, flavonoids, tannins, etc) are unable to reach their target sites due to their low water solubility, less cellular absorption, and high molecular weight, leading to their failure into clinical translation. Therefore, many scientific studies are going on to overcome the drawbacks of natural products for clinical applications. Several studies in India, as well as worldwide, have proposed the development of natural products-based nanoformulations to increase their efficacy and safety profile for cancer therapy by improving the delivery of natural bioactive compounds to their target site. Therefore, we are trying to discuss the development of natural products-based nanoformulations in India to improve the efficacy and safety of natural bioactive compounds against cancer.
药用植物的使用可以追溯到人类文明的起源。植物化学和药理学的发展促进了对天然生物活性化合物及其作用机制的鉴定,包括抗癌作用。生物活性化合物的疗效和安全性取决于其在靶部位的最佳传递。大多数天然生物活性化合物(酚类、类黄酮、单宁等)由于其低水溶性、低细胞吸收性和高分子量,无法到达其靶部位,导致其无法进入临床转化。因此,许多科学研究正在进行,以克服天然产物用于临床应用的缺点。印度和世界各地的许多研究都提出了开发基于天然产物的纳米制剂,通过改善天然生物活性化合物向靶部位的传递,提高其治疗癌症的疗效和安全性。因此,我们试图讨论印度基于天然产物的纳米制剂的开发,以提高天然生物活性化合物对癌症的疗效和安全性。